Preparedness for and Response to Meningococcal Outbreaks: a Pilot Study of the Immunogenicity, Reactogenicity and Tolerability of Two Schedules of a 4CmenB Vaccine in Adolescents and Young Adults
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary) ; Meningococcal vaccine group B OMV Novartis (Primary)
- Indications Meningococcal group B infections
- Focus Therapeutic Use
- 08 Apr 2017 Planned End Date changed from 1 Oct 2016 to 30 Jun 2017.
- 22 Jun 2016 Planned End Date changed from 1 Mar 2016 to 1 Oct 2016.
- 22 Jun 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Sep 2016.